Clinical characteristics and survival in never smokers with lung cancer;Características clínicas y supervivencia de los pacientes nunca fumadores con cáncer de pulmón

Archivos de Bronconeumologia

Volumn 50, Issue 2, 2014, Pages 62-66

  Parente Lamelas, Isaura ^a   Abal Arca, José ^a   Blanco Cid, Nagore ^a   Alves Pérez, María Teresa ^a   Dacal Quintas, Raquel ^a   Gómez Márquez, Hugo ^a   García Montenegro, Rogelio Alejandro ^a   Marcos Velázquez, Pedro ^a  

^a Servicio de Obstetricia y Ginecología   (Spain)

Author keywords

Epidemiology; Lung cancer; Never smokers; Smokers; Survival

Indexed keywords

AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LUNG SURGERY; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SMOKING; SURVIVAL RATE; ADVANCED CANCER; CANCER PROGNOSIS; COMORBIDITY; LARGE CELL LUNG CARCINOMA; OBSERVATIONAL STUDY; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA;

EID: 84895076246     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2014.01.010     Document Type: Article

References (32)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
3. INE. Defunciones según la Causa de Muerte. Año 2009 [consultado 23 Feb 2012]. Disponible en: http://www.ine.es/prensa/np664.pdf.
4. Sánchez M.J., Payer T., de Angelis R., Larrañaga N., Cappocaccia R., Martínez C., et al. Cancer incidence and mortality in Spain: Estimates and projections for the period 1981-2012. Ann Oncol 2010, 21(Suppl 3):iii30-iii36.
5. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62:10-29.
6. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Thun M.J. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
7. Hospices civils de Lyon/Institut de veille sanitaire/Institut national du cancer/Francim/Institut national de la santé et de la recherche médicale. Projections de l'incidence et de la mortalité par cancer en France en 2011 [consultado 2 Dic 2012]. Disponible en: http://www.invs.sante.fr/Dossiers-thematiques/Maladies-chroniques-et traumatismes/Cancers/Surveillance-epidemiologiquedes-cancers/Projections-Estimations-de-l-incidence-et-de-la-mortalite/Projections-de-l-incidence-et-de-la-mortalite-par-cancer-en-France-en-2011.
8. Vineis P., Airoldi L., Veglia F., Olgialti R., Pastorelli R., Autrup H., et al. Environmental tobacco smoke and risk of respiratory cancer and chronic obstructive pulmonary disease in former smokers and never smokers in the EPIC prospective study. BMJ 2005, 330:277.
9. Ruano A., Prini L., Barros J.M., Abal J., Leiro V., González A.I., et al. Exposición a radón residencial y cáncer de pulmón en nunca fumadores. Resultados preliminares del estudio LCRINS. Arch Bronconeumol 2012, 48:405-409.
10. Rudin C.M., Avila-Tang E., Harris C.C., Herman J.G., Hirsch F.R., Pao W., et al. Lung cancer in never smokers: Molecular profiles and therapeutic implications. Clin Cancer Res 2009, 15:5646-5661.
11. Brambilla E., Travis W.D., Colby T.V., Corrin B., Shimosato Y. The new World Health Organization classification of lung tumours. Eur Respir J 2001, 18:1059-1068.
12. Goldstraw P., Crowley J., Chansky K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007, 2:706-714.
13. WHO guidelines for controlling and monitoring the tobacco epidemic 1998, World Health Organization, Geneva, Switzerland.
14. Yano T., Miura N., Takenaka T., Haro A., Okazaki H., Ohba T., et al. Never-smoking nonsmall cell lung cancer as a separate entity: Clinicopathologic features and survival. Cancer 2008, 113:1012-1018.
15. Samet J.M., Avila-Tang E., Boffeta P., Hannan L.M., Olivo-Marston S., Thun M.J. Lung cancer in never smokers: Clinical epidemiology and environmental risk factors. Clin Cancer Res 2009, 15:5625-5645.
16. Koo L.C., Ho J.M-C. Worldwide epidemiological patterns of lung cancer in non smokers. Int J Epidemiol 1990, 19:s14-s23.
17. Devesa S.S., Bray F., Vizcaino A.P., Parkin D.M. International lung cancer trends by histologic type: Male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005, 117:294-299.
18. Pham D., Kris M.G., Riely G.J., Sarkaria I.S., McDonough T., Chuai S., et al. Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas. J Clin Oncol 2006, 24:1700-1704.
19. Marchetti A., Martella C., Felicioni L., Barassi F., Salavtore S., Chella A., et al. EGFR mutations in non-small-cell lung cancer: Analysis of a large series and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol 2005, 23:857-865.
20. Riely G.J., Kris M.G., Rosenbaum D., Marks J., Li A., Chitale D.A., et al. Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma. Clin Cancer Res 2008, 14:5731-5734.
21. Dibble R., Langeburg W., Bair S., Ward J., Akerley W. Natural history of non-small cell lung cancer in non-smokers. J Clin Oncol 2005, 23:683s. abstr 7252.
22. Miller V.A., Kris M.G., Shahn N., Patel J., Azzoli C., Gomez J., et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol 2004, 22:1103-1109.
23. Shepherd F.A., Rodrigues Pereira J., Ciuleanu T., Tan E.H., Hirsh V., Thongprasert S., et al. Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 2005, 353:123-132.
24. Sánchez de Cos J., Disdier C., Corral J., Riesco J.A., Sojo M.A., Masa J.F. Supervivencia global a largo plazo en el cáncer de pulmón. Análisis de una serie de 610 pacientes no seleccionados. Arch Bronconeumol 2004, 40:268-274.
25. Fry W.A., Phillips J.L., Menck H.R. Ten-year survey of lung cancer treatment and survival in hospital in the United States. Cancer 1999, 86:1867-1876.
26. Parente Lamelas I., Abal Arca J., Alves Pérez M.T., García García M.J., Marcos Velázquez P. Long term lung cancer survival in a province of Spain. J Pulmonar Respirat Med 2012, S5:001. doi:10.4172/2161-105X.S5-001.
27. Nordquist L.T., Simon G.R., Cantor A., Michael W., Bepler G. Improved survival in never-smokers versus current smokers with primary adenocarcinoma of the lung. Chest 2004, 126:347-351.
28. Toh C-K., Wong E-H., Lim W-T., Leong S-S., Fong K-W., Wee J., et al. The impact of smoking status on the behavior and survival outcome of patients with advanced non-small cell lung cancer: A retrospective analysis. Chest 2004, 126:1750-1756.
29. Cerfolio R.J., Bryant A.S., Scott E., Sharma M., Robert F., Spencer S.A., et al. Women with pathologic stage I, II, and III non-small cell lung cancer have better survival than men. Chest 2006, 130:1796-1802.
30. Kirsh M.M., Tashian J., Sloan H. Carcinoma of the lung in women. Ann Thorac Surg 1982, 34:34-39.
31. Parente I., Abal J., García M.J., García J.M., Acuña A., Marcos P. Cáncer de pulmón en mujeres, comparativo con hombres: análisis de los casos diagnosticados en el Complexo Hospitalario de Ourense entre 1999 y 2006. Arch Bronconeumol 2011, 47:61-65.
32. Salmerón D., Chirlaque M.D., Isabel M., Sánchez M.J., Marcos-Gragera R., Ardanaz E., et al. Lung cancer prognosis in Spain: The role of histology, age and sex. Respir Med 2012, 106:13018.